Gadoquatrane, a contrast agent Bayer is developing for use in MRI scans, like those done in MS, uses 60% less gadolinium and ...
Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly ...
The ARIES-HM3 substudy may help persuade implanters who are less well-versed in the circulatory changes an LVAD affords.
The pharmaceutical company’s latest partnership with Incremental and Skai drove a 32% boost in iROI, delivering nearly a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback